companies

Abertis gets €250 million selling its shares in the Portuguese company Brisa

August 8, 2012 09:27 PM | CNA

The Catalan highway, transport and telecommunication management company Abertis has accepted Tagus’ takeover of its shares in Brisa, which represent 15.02% of the Portuguese highway company. Abertis now wants to focus on projects that represent added value for its global strategic action. In addition, two days ago, Abertis’ board ratified last April’s agreement to acquire 9 highway concessions from OHL in Brazil. With this operation, the Catalan company becomes the largest group in the world managing highways, with more than 7,000 kilometres worldwide.

Grifols makes net profit of €133.5 million in the first half of 2012

July 31, 2012 07:42 PM | CNA / David Tuxworth

The Catalan pharmaceutical company Grifols, the third world leader in the production of blood plasma based technologies, has seen its turnover increase by 15% in the first half of 2012 to €1.32 billion. Its net profit for the first half of 2012 was €133.5 million, seven times that of the previous year. The company’s success is attributed to its wide geographical consumer base and the recent purchase of US based Talecris Plasma Resources.

Xavier Trias completes successful visit to China to promote investment in Barcelona

July 17, 2012 09:50 PM | Paula Mateu / David Tuxworth

The Mayor of Barcelona, Xavier Trias has finished a seven-day visit to China. The aim of the trip was to promote Barcelona’s economy and attract new foreign investment in the Catalan capital. The Mayor spoke of the trip in a very positive light, pointing out the economic potential of Barcelona and highlighting the Chinese companies’ appreciation for the opportunity to invest in Barcelona.

Catalonia is presented as a biotechnological cluster at Bio Boston 2012

June 23, 2012 12:00 AM | CNA

The President of the Catalan Government, Artur Mas, travelled to Massachusetts and New York to promote Catalan businesses and present Catalonia as one of the main biotechnological clusters and tourist destinations in Europe. In addition, Ernst & Young presented their report on life sciences companies and research centres in Catalonia, which indicates that almost 30% of this sector’s turnover in Spain comes from Catalan businesses.

Grifols strengthens its presence in the Chinese market

May 22, 2012 03:33 PM | CNA / Laura Quintana

The Catalan pharmaceutical company Grífols, third worldwide company in plasma derivatives, has signed a cooperation agreement with the Shanghai Blood Bank. The agreement, which strengthens the presence of the Catalan company in China, promotes blood genotyping research. The Chinese institution will use the Grifols’ genetic test BLOODchip in transfusion compatibility studies. Shanghai Blood Bank serves over 20 million people and receives more than 300.000 donations per year. In 2011, Grifols sales in China grew by 30%.

Catalan Mesoestetic Pharma Group exports 85% of its production and is present in 62 markets worldwide

May 19, 2012 12:18 AM | CNA / Bertran Cazorla

The Catalan company Mesoestetic has built a new factory that multiplies by ten its previous facilities. Furthermore, the company will increase its staff by 30%. The Catalan Minister for Business and Employment has praised the company as a model for innovation and internationalisation. He has spoke of the long tradition of the pharmaceutical industry in Catalonia as well as the Catalan economy’s export capacity.

Catalan cooperative La Fageda awarded for its social integration work

May 11, 2012 09:58 PM | CNA / Laia Vicens

The BBVA bank rewards La Fageda with the 4th Integra Prize for offering quality employment for people with intellectual disabilities and mental disorders. Moreover, La Fageda carries out some care activities, like an occupational therapy service, assisted apartments for the workers, and different leisure activities. Nowadays, of the 287 people who work in La Fageda, 157 have some disability. The Catalan brand is famous for its quality dairy products.